Table 3.
Bivariate correlation analysis between study parameters and serum osteoprotegerin levels.
| Parameters | Bivariate correlation | |
|---|---|---|
| r | p value | |
| Age | 0.453 | <0.001 |
| Height | −0.115 | 0.058 |
| Weight | −0.082 | 0.178 |
| BMI | −0.036 | 0.552 |
| Waist circumference | 0.078 | 0.203 |
| Hip circumferences | −0.005 | 0.793 |
| Waist-to-hip ratio | 0.125 | 0.039 |
| Body fat percentage | 0.213 | <0.001 |
| ALT | −0.014 | 0.823 |
| AST | 0.086 | 0.157 |
| ALP | 0.175 | 0.004 |
| BUN | 0.025 | 0.688 |
| Cr | 0.193 | 0.001 |
| Calcium | −0.001 | 0.981 |
| URCA | 0.046 | 0.451 |
| TC | −0.006 | 0.924 |
| TG | 0.027 | 0.660 |
| HDL-C | 0.012 | 0.847 |
| LDL-C | −0.077 | 0.207 |
| FPG | 0.093 | 0.133 |
| 2hPG | 0.270 | <0.001 |
| HbA1c | 0.214 | <0.001 |
| FINS | 0.106 | 0.080 |
| Ln HOMA-IR | 0.134 | 0.027 |
| HOMA-B | −0.037 | 0.546 |
| QUICKI | −0.194 | 0.001 |
| eGFR | −0.331 | <0.001 |
| Lumbar BMD | −0.189 | 0.002 |
| Femoral neck BMD | −0.130 | 0.032 |
2hPG, 2 h postprandial plasma glucose; ALP, alkaline phosphatase; ALT, alanine aminotransferase; AST, aspartate aminotransferase; BMD, bone mineral density; BMI, body mass index; BUN, blood urea nitrogen; Cr, creatinine; eGFR, estimate glomerular filtration rate; FINS, fasting insulin; FPG, fasting plasma glucose; HbA1c, glycated hemoglobin; HDL-C, high-density lipoprotein cholesterol; HOMA-B, homeostasis model assessment of β-cell function; LDL-C, low-density lipoproteincholesterol; Ln HOMA-IR, natural logarithmic transformation homeostasis model of assessment for insulin resistance index; OPG, osteoprotegerin; QUICKI, quantitative insulin sensitivity check index; SBP, systolic blood pressure; SDP, diastolic blood pressure; TC, total cholesterol; TG, triglycerides; URCA, blood uric acid.